Inari Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Revenue	493.63	383.47	276.98	139.67	51.13	6.83
Revenue Growth (YoY)	28.73%	38.45%	98.31%	173.17%	648.70%	-
Cost of Revenue	59.07	44.51	24.76	13.11	5.91	1.28
Gross Profit	434.56	338.97	252.23	126.56	45.22	5.55
Selling, General & Admin	361.06	292.84	190.37	89.75	37.2	10.7
Research & Development	87.53	74.22	51.02	18.4	7.22	3.99
Operating Expenses	448.6	367.06	241.38	108.15	44.42	14.69
Operating Income	-14.03	-28.1	10.84	18.42	0.8	-9.14
Interest Expense / Income	0.2	0.29	0.3	1.14	0.92	0.89
Other Expense / Income	-18.47	-2.21	-0.14	3.5	1.07	0.13
Pretax Income	4.25	-26.19	10.69	13.79	-1.19	-10.15
Income Tax	5.88	3.08	0.85	0	0	0
Net Income	-1.64	-29.27	9.84	13.79	-1.19	-10.15
Net Income Growth	-	-	-28.64%	-	-	-
Shares Outstanding (Basic)	57	53	50	32	6	5
Shares Outstanding (Diluted)	57	53	56	52	6	5
Shares Change	7.44%	-4.96%	7.83%	775.66%	16.43%	-
EPS (Basic)	-0.03	-0.55	0.20	0.43	-0.20	-2.01
EPS (Diluted)	-0.03	-0.55	0.18	0.27	-0.20	-2.01
EPS Growth	-	-	-33.33%	-	-	-
Free Cash Flow	29.73	-23.92	11.84	-3.55	-8.08	-11.65
Free Cash Flow Per Share	0.52	-0.45	0.24	-0.11	-1.37	-2.30
Gross Margin	88.03%	88.39%	91.06%	90.62%	88.44%	81.24%
Operating Margin	-2.84%	-7.33%	3.92%	13.19%	1.57%	-133.84%
Profit Margin	-0.33%	-7.63%	3.55%	9.87%	-2.33%	-148.67%
Free Cash Flow Margin	6.02%	-6.24%	4.27%	-2.54%	-15.80%	-170.52%
Effective Tax Rate	138.53%	-	7.91%	-	-	-
EBITDA	15.18	-18.77	15.29	16.31	0.34	-8.98
EBITDA Margin	3.07%	-4.90%	5.52%	11.68%	0.67%	-131.54%
Depreciation & Amortization	10.74	7.12	4.31	1.39	0.61	0.28
EBIT	4.44	-25.89	10.98	14.92	-0.27	-9.27
EBIT Margin	0.90%	-6.75%	3.96%	10.69%	-0.53%	-135.69%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).